ABT logo
ABT@NYSE
Abbott Laboratories
$ 99.60+1.11 (+1.13%)
Buy ABT
OpenPrice at market open
—
LowLowest price today
—
52-Week HighHighest past 52 weeks
—
HighHighest price today
—
52-Week LowLowest past 52 weeks
—
Market Cap.Total company value
170.43B
Today’s VolumeShares traded today
11.94M
Avg. VolumeAverage shares traded
10.74M
P/E RatioPrice to earnings ratio
31.67

Company Profile

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

IPO Date
1980-03-17
Headquarters
Abbott Park, US
CEO
Robert Ford
Sector
Healthcare
Industry
Medical - Devices

Financial Statements

Earnings

Related Companies

BDX logo
BDXBecton, Dickinson and Company
183.75
BSX logo
BSXBoston Scientific Corporation
42.73
DHR logo
DHRDanaher Corporation
219.87
EW logo
EWEdwards Lifesciences Corporation
85.21

Unlok the Future of Trading

Seamless access to global markets with AI-powered insights for smarter, more confident trading.

Device mockup